Activist investor Carl Icahn has dropped his controversial opposition to the merger of insurer Cigna and pharmacy benefit manager Express Scripts, after previously bashing the $60 billion deal.
Icahn’s investment firm said in a statement late Monday that he was abandoning his attempt to stop the deal, but did not elaborate. Icahn holds a small stake in Cigna.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.
